For Q4 2025, Select Medical generated revenue of 1396634000, up 6.4% year over year. Income from continuing operations, net of tax, was 37742000, compared to a loss in the prior year period. Diluted EPS from continuing operations was 0.16 and Adjusted EBITDA was 104664000.

Select Medical Holdings Corporation experienced a mixed financial performance in Q1 2025. While total revenue increased to $1,353,172,000, net income attributable to common stockholders decreased to $56,681,000 from $96,897,000 in the prior year. Adjusted EBITDA also saw a decline, primarily driven by lower revenue in the Critical Illness Recovery Hospital segment and increased labor costs in Outpatient Rehabilitation, partially offset by strong performance in the Rehabilitation Hospital segment.

Select Medical Holdings Corporation reported a 7.8% increase in revenue for Q4 2024, reaching $1.31 billion. However, the company posted a net loss from continuing operations of $10.5 million due to a one-time stock compensation acceleration of $45.9 million and a $17.9 million loss on early retirement of debt. Adjusted EPS increased by 50% to $0.18. Adjusted EBITDA rose 3.8% to $116.0 million.

Select Medical Holdings Corporation reported a 5.7% increase in revenue, reaching $1,761.2 million for the third quarter ended September 30, 2024. Net income increased by 33.2% to $81.0 million, and earnings per common share increased by 13.2% to $0.43.

Select Medical Holdings Corporation reported a 5.1% increase in revenue to $1,759.7 million for the second quarter ended June 30, 2024, compared to $1,674.5 million for the same quarter, prior year. Net income increased 3.2% to $94.8 million, and earnings per share were $0.60.

Select Medical Holdings Corporation reported a 7.4% increase in revenue to $1,788.8 million for the first quarter ended March 31, 2024, compared to $1,665.0 million for the same quarter, prior year. Net income increased 37.4% to $117.2 million, and earnings per share increased 33.9% to $0.75.

Select Medical Holdings Corporation reported a 4.9% increase in revenue to $1,658.9 million for the fourth quarter ended December 31, 2023. Net income increased 63.9% to $61.8 million, and earnings per common share increased 63.6% to $0.36.

Select Medical Holdings Corporation reported a 6.2% increase in revenue to $1,665.7 million for the third quarter ended September 30, 2023, compared to $1,567.8 million for the same quarter, prior year. Net income increased 59.5% to $60.8 million. Earnings per common share increased 75.8% to $0.38, and adjusted earnings per common share increased 113.7% to $0.46.

Select Medical Holdings Corporation reported a 5.7% increase in revenue to $1,674.5 million for the second quarter ended June 30, 2023, compared to $1,584.7 million for the same quarter, prior year. Net income increased 38.6% to $91.9 million, and earnings per share increased 44.0% to $0.61.

Select Medical Holdings Corporation reported a 4.1% increase in revenue to $1,665.0 million for the first quarter ended March 31, 2023, compared to $1,599.5 million for the same quarter prior year. Net income increased 52.4% to $85.3 million, compared to $55.9 million for the same quarter, prior year.

Select Medical Holdings Corporation reported a revenue increase of 1.4% to $1,581.5 million for the fourth quarter ended December 31, 2022. However, net income decreased to $37.7 million compared to $66.3 million for the same quarter prior year. Earnings per common share was $0.22 for the fourth quarter ended December 31, 2022, compared to $0.37 for the same quarter, prior year.

Select Medical Holdings Corporation reported a revenue increase of 2.2% to $1,567.8 million for the third quarter ended September 30, 2022. However, net income decreased to $38.1 million, and earnings per common share was $0.21, compared to $100.2 million and $0.57, respectively, for the same quarter last year.

Select Medical Holdings Corporation reported a 1.3% increase in revenue to $1,584.7 million for the second quarter ended June 30, 2022, compared to $1,564.0 million for the same quarter, prior year. Net income was $66.3 million, compared to $196.2 million for the same quarter, prior year. Earnings per common share was $0.43, compared to $1.22 for the same quarter, prior year.

Select Medical Holdings Corporation announced its first quarter results for the period ended March 31, 2022. Revenue increased by 3.4% to $1,599.5 million, while net income decreased to $55.9 million, and income from operations decreased to $104.0 million.

Select Medical Holdings Corporation reported a 6.8% increase in revenue to $1,559.8 million for the fourth quarter ended December 31, 2021, compared to $1,460.5 million for the same quarter the prior year. Net income was $66.3 million, compared to $102.2 million for the same quarter the prior year. Earnings per common share was $0.37, compared to $0.57 for the same quarter the prior year.

Select Medical Holdings Corporation reported a 7.8% increase in revenue to $1,534.2 million for the third quarter ended September 30, 2021, compared to $1,423.9 million for the same quarter, prior year. Net income was $100.2 million, compared to $104.5 million for the same quarter, prior year.

Select Medical Holdings Corporation announced strong second-quarter results with a 26.9% increase in revenue to $1,564.0 million and a 190.7% increase in net income to $196.2 million compared to the same quarter last year. Earnings per share increased to $1.22, and adjusted EBITDA rose by 91.3% to $342.0 million.

Select Medical Holdings Corporation reported a revenue increase of 9.3% to $1,546.5 million, with net income rising by 94.8% to $137.2 million and earnings per share increasing to $0.82 for the first quarter ended March 31, 2021.

Select Medical Holdings Corporation reported a revenue increase of 6.2% to $1,460.5 million for the fourth quarter ended December 31, 2020. Net income increased by 134.1% to $102.2 million, and earnings per share increased to $0.57 on a fully diluted basis.

Select Medical Holdings Corporation reported a 2.2% increase in net operating revenues to $1,423.9 million for the third quarter ended September 30, 2020. Net income increased by 137.2% to $104.5 million, and earnings per common share was $0.57 on a fully diluted basis.

Select Medical reported net operating revenues of $1,232.7 million for the second quarter ended June 30, 2020, compared to $1,361.4 million for the same quarter, prior year. Net income increased 12.5% to $67.5 million, and earnings per common share was $0.39 on a fully diluted basis.

Select Medical Holdings Corporation reported a strong first quarter for 2020, with a 6.8% increase in net operating revenues to $1,414.6 million and a 32.1% increase in net income to $70.4 million. Earnings per share increased to $0.40, and adjusted earnings per share was $0.37.

Select Medical Holdings Corporation announced its Q4 2019 results, with net operating revenues increasing by 8.7% to $1,374.6 million, income from operations increasing by 27.3% to $112.4 million, and net income increasing by 46.9% to $43.7 million compared to the same quarter of the prior year. Adjusted EBITDA increased by 16.9% to $171.9 million, and adjusted earnings per common share was $0.31 on a fully diluted basis.